MedTrace Logo

Immediate Postpartum Glucose Tolerance Testing

NCT04199676 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-09-03

No results posted yet for this study

Summary

The objective of this study is to compare the accuracy of a 2hr glucose tolerance test administered during the postpartum hospitalization with the standard of care glucose tolerance testing (administered at 6 weeks postpartum). The primary hypothesis is that the glucose tolerance test administered in the postpartum period will be accurate and will improve compliance with postpartum testing for gestational diabetics.

Conditions

  • Gestational Diabetes

Interventions

DIAGNOSTIC_TEST

Glucose tolerance test

Oral administration of a 75g glucose tolerance test during the postpartum hospitalization

Sponsors & Collaborators

  • MemorialCare Health System

    lead OTHER

Principal Investigators

  • Alice Sherman-Brown, MD · Magella Medical Group

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04199676 on ClinicalTrials.gov